0,949  0,002  Cardiovascular analeptic
0,947  0,001  Sensitization
0,911  0,005  Antiinflammatory
0,889  0,004  Antileukemic
0,866  0,009  Apoptosis agonist
0,842  0,010  Transcription factor NF kappa B inhibitor
0,837  0,006  Antineoplastic (breast cancer)
0,825  0,004  Nitric oxide antagonist
0,812  0,007  Antineoplastic (lung cancer)
0,808  0,004  Analeptic
0,770  0,004  Antineoplastic (pancreatic cancer)
0,757  0,010  Antineoplastic (colorectal cancer)
0,752  0,010  Antineoplastic (colon cancer)
0,711  0,005  Antineoplastic (glioma)
0,705  0,005  Immunosuppressant
0,706  0,018  CYP3A4 substrate
0,662  0,008  Antiparasitic
0,657  0,005  Antihelmintic
0,663  0,012  Prostate cancer treatment
0,657  0,009  Cytostatic
0,649  0,012  Antineoplastic (ovarian cancer)
0,638  0,005  Antineoplastic (liver cancer)
0,636  0,008  Antipsoriatic
0,632  0,011  Bone diseases treatment
0,634  0,015  Respiratory analeptic
0,621  0,007  Antineoplastic (multiple myeloma)
0,611  0,017  Antiprotozoal
0,587  0,006  Antineoplastic (lymphoma)
0,586  0,004  Platelet adhesion inhibitor
0,587  0,006  Antineoplastic (carcinoma)
0,593  0,013  Antiprotozoal (Plasmodium)
0,587  0,009  Antipyretic
0,586  0,013  Cytotoxic
0,574  0,007  Antineoplastic (glioblastoma multiforme)
0,583  0,022  Antibacterial
0,548  0,018  Antineoplastic (melanoma)
0,542  0,014  NOS2 expression inhibitor
0,532  0,006  Antiulcerative
0,526  0,006  Antineoplastic (squamous cell carcinoma)
0,533  0,017  Antiosteoporotic
0,517  0,019  Antifungal
0,515  0,018  Chemopreventive
0,493  0,004  Antifungal enhancer
0,512  0,029  Antipruritic, allergic
0,488  0,012  Antineoplastic (endocrine cancer)
0,478  0,009  Diuretic
0,477  0,010  Antineoplastic (sarcoma)
0,490  0,024  Hepatic disorders treatment
0,470  0,007  Contraceptive
0,479  0,016  ICAM1 expression inhibitor
0,464  0,007  Antiacne
0,458  0,004  Aromatase inhibitor
0,460  0,007  Prostate disorders treatment
0,496  0,047  TNF expression inhibitor
0,454  0,008  Interferon gamma antagonist
0,448  0,015  Antineoplastic enhancer
0,436  0,007  Antialcoholic
0,456  0,028  Antineoplastic (cervical cancer)
0,446  0,030  Radioprotector
0,413  0,006  Sepsis treatment
0,429  0,025  Proliferative diseases treatment
0,434  0,032  AR expression inhibitor
0,407  0,008  Pneumotoxic
0,415  0,019  Antineoplastic (osteosarcoma)
0,421  0,033  Apoptosis antagonist
0,390  0,004  T cell inhibitor
0,418  0,034  Cardioprotectant
0,411  0,028  Antiprotozoal (Leishmania)
0,391  0,007  Antiviral (Influenza A)
0,387  0,018  Abortion inducer
0,380  0,014  Prostatic (benign) hyperplasia treatment
0,383  0,025  Sigma receptor agonist
0,369  0,026  DNA synthesis inhibitor
0,368  0,027  Transcription factor STAT3 inhibitor
0,370  0,038  Calcium channel activator
0,369  0,041  Antioxidant
0,341  0,016  Antipruritic, non-allergic
0,343  0,020  Hepatoprotectant
0,342  0,020  Antiviral (Influenza)
0,368  0,054  Immunomodulator
0,359  0,049  Antineoplastic (brain cancer)
0,346  0,037  Mutagenic
0,335  0,042  Platelet antagonist
0,297  0,005  Antifungal (Cryptococcus)
0,341  0,053  Teratogen
0,290  0,003  Hypercalcemia treatment
0,326  0,043  Antineoplastic (renal cancer)
0,286  0,007  Farnesoid X receptor antagonist
0,309  0,040  Antineoplastic (lymphocytic leukemia)
0,275  0,007  Contraceptive female
0,280  0,015  Antidiabetic (type 1)
0,264  0,005  Microtubule formation inhibitor
0,308  0,051  Transcription factor STAT inhibitor
0,290  0,050  5 Hydroxytryptamine uptake stimulant
0,270  0,034  UGT2B7 substrate
0,295  0,060  Embryotoxic
0,239  0,004  Opioid kappa receptor agonist
0,303  0,073  NOS3 expression inhibitor
0,278  0,049  Carcinogenic
0,232  0,008  Opioid kappa receptor antagonist
0,236  0,014  Expectorant
0,359  0,138  Caspase 9 stimulant
0,284  0,064  Chemoprotective
0,305  0,085  Antithrombotic
0,251  0,038  Neurotrophic factor enhancer
0,237  0,026  Interleukin 6 antagonist
0,214  0,004  Glycine receptor agonist
0,226  0,017  Antineoplastic antibiotic
0,242  0,036  Lipocortins synthesis antagonist
0,264  0,069  Tumour necrosis factor alpha release inhibitor
0,227  0,035  Hair growth stimulant
0,194  0,004  Glycine receptor antagonist
0,232  0,046  UGT1A4 substrate
0,187  0,002  Vitamin D receptor antagonist
0,216  0,032  UGT2B9 substrate
0,195  0,014  Androgen antagonist
0,254  0,076  Interleukin agonist
0,184  0,006  Anabolic
0,280  0,105  Cholesterol antagonist
0,212  0,040  Amylase inhibitor
0,202  0,031  Arachidonic acid antagonist
0,180  0,013  Actinic keratosis treatment
0,205  0,039  Melanin inhibitor
0,231  0,065  Antiparkinsonian, rigidity relieving
0,223  0,059  UDP-glucuronosyltransferase substrate
0,201  0,037  Antirickettsial
0,224  0,064  VCAM1 expression inhibitor
0,267  0,110  Sodium/bile acid cotransporter inhibitor
0,166  0,014  Chymotrypsin inhibitor
0,172  0,022  Mucolytic
0,151  0,007  5-Alpha-reductase inhibitor
0,155  0,013  Paget's disease treatment
0,217  0,077  RNA-directed DNA polymerase inhibitor
0,186  0,047  Protein kinase stimulant
0,196  0,059  LDLR expression enhancer
0,143  0,007  Na+ K+ transporting ATPase inhibitor
0,232  0,102  Gastrin inhibitor
0,168  0,038  Adenylate cyclase stimulant
0,205  0,077  Psychostimulant
0,161  0,033  Interleukin 1b antagonist
0,153  0,027  Antineoplastic alkaloid
0,220  0,094  Antineoplastic (non-small cell lung cancer)
0,217  0,092  Vasodilator
0,181  0,060  Antihelmintic (Nematodes)
0,225  0,111  UGT2B4 substrate
0,116  0,003  Parathyroid hormone antagonist
0,134  0,023  Antibiotic
0,165  0,057  Antidiarrheal
0,135  0,032  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,165  0,063  Acute respiratory distress syndrome (ARDS) treatment
0,184  0,082  CYP2B6 inhibitor
0,185  0,083  UGT1A1 substrate
0,149  0,054  Pregnane X receptor agonist
0,220  0,127  Antihypoxic
0,110  0,018  Narcotic antagonist
0,165  0,075  UGT2B10 substrate
0,116  0,026  Inducible nitric-oxide synthase inhibitor
0,120  0,031  Antispirochetal
0,206  0,119  Lipoprotein disorders treatment
0,226  0,141  CYP3A4 inhibitor
0,202  0,119  Immunostimulant
0,161  0,082  Muscle relaxant
0,133  0,055  Growth stimulant
0,205  0,127  CYP2C19 substrate
0,148  0,071  Genotoxic
0,092  0,015  Protein 50S ribosomal subunit inhibitor
0,087  0,010  Postcoital contraceptive
0,115  0,038  Opioid antagonist
0,106  0,030  Contraceptive male
0,141  0,068  Ca2+-transporting ATPase inhibitor
0,221  0,149  GST M1-1 substrate
0,178  0,106  Angiogenesis stimulant
0,109  0,039  ABCA1 expression enhancer
0,074  0,004  CYP24 inhibitor
0,160  0,091  Toxic, respiratory center
0,167  0,097  Anesthetic general
0,209  0,142  Antimycobacterial
0,086  0,018  Glutamate (mGluR6) antagonist
0,186  0,119  Peptidyltransferase inhibitor
0,126  0,059  Protein-tyrosine phosphatase 1B inhibitor
0,164  0,099  Septic shock treatment
0,068  0,004  Tubulin agonist
0,097  0,033  Keratolytic
0,085  0,021  Androgen agonist
0,094  0,031  CDC25A inhibitor
0,074  0,013  Aldosterone antagonist
0,082  0,021  Postmenopausal disorders treatment
0,128  0,069  Vanilloid 1 agonist
0,078  0,020  Opioid agonist
0,065  0,009  Microtubule stabilization
0,131  0,075  Interleukin 1 antagonist
0,135  0,083  Acaricide
0,071  0,021  Lipocortins synthesis agonist
0,120  0,070  Antiprotozoal (Amoeba)
0,132  0,083  UGT2B15 substrate
0,173  0,124  Antihypercholesterolemic
0,102  0,055  UGT2B11 substrate
0,124  0,080  Cocaine dependence treatment
0,137  0,093  Protein-tyrosine phosphatase inhibitor
0,114  0,071  Cholesterol synthesis inhibitor
0,076  0,034  Hyperparathyroidism treatment
0,046  0,004  Prostacyclin agonist
0,113  0,072  Shock treatment
0,102  0,062  5-Lipoxygenase inhibitor
0,217  0,179  CYP2C9 substrate
0,203  0,165  Caspase 3 stimulant
0,089  0,053  Transcription factor NF kappa B stimulant
0,121  0,085  Bone formation stimulant
0,095  0,061  Bile acid receptor antagonist
0,058  0,025  Anesthetic inhalation
0,051  0,018  Progesterone antagonist
0,067  0,035  Antimycoplasmal
0,062  0,029  Estrogen agonist
0,056  0,025  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,071  0,041  SULT2A1 substrate
0,034  0,004  Progesterone receptor B antagonist
0,087  0,059  Ornithine decarboxylase inhibitor
0,148  0,120  P-glycoprotein inhibitor
0,174  0,147  Antihypotensive
0,041  0,016  RNA-directed RNA polymerase stimulant
0,095  0,071  Carcinogenic, group 2B
0,031  0,007  Progesterone agonist
0,070  0,047  Anticholelithogenic
0,036  0,013  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,144  0,123  Non-steroidal antiinflammatory agent
0,080  0,063  Antiprotozoal activity enhancer
0,099  0,085  Antitussive
0,100  0,086  Carcinogenic, group 3
0,033  0,020  ATP citrate lysase inhibitor
0,024  0,011  Corticosteroid-like
0,163  0,151  Spasmolytic
0,018  0,009  Vitamin D receptor agonist
0,078  0,069  Antiviral (Trachoma)
0,010  0,001  Vitamin D-like
0,098  0,090  TRPA1 agonist
0,217  0,213  CYP2C19 inhibitor
0,013  0,010  Antibiotic Macrolide-like
0,030  0,028  Glutamate (mGluR3) agonist
0,027  0,026  Glucocorticoid antagonist
0,008  0,008  Progesterone receptor A antagonist

